258 related articles for article (PubMed ID: 31811476)
1. TCGA Molecular Subgroups in Endometrial Undifferentiated/Dedifferentiated Carcinoma.
Travaglino A; Raffone A; Mascolo M; Guida M; Insabato L; Zannoni GF; Zullo F
Pathol Oncol Res; 2020 Jul; 26(3):1411-1416. PubMed ID: 31811476
[TBL] [Abstract][Full Text] [Related]
2. TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
Travaglino A; Raffone A; Gencarelli A; Mollo A; Guida M; Insabato L; Santoro A; Zannoni GF; Zullo F
Pathol Oncol Res; 2020 Oct; 26(4):2067-2073. PubMed ID: 32472441
[TBL] [Abstract][Full Text] [Related]
3. Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups.
Travaglino A; Raffone A; Stradella C; Esposito R; Moretta P; Gallo C; Orlandi G; Insabato L; Zullo F
Arch Gynecol Obstet; 2020 Jun; 301(6):1355-1363. PubMed ID: 32296930
[TBL] [Abstract][Full Text] [Related]
4. TCGA molecular groups of endometrial cancer: Pooled data about prognosis.
Raffone A; Travaglino A; Mascolo M; Carbone L; Guida M; Insabato L; Zullo F
Gynecol Oncol; 2019 Nov; 155(2):374-383. PubMed ID: 31472940
[TBL] [Abstract][Full Text] [Related]
5. TCGA molecular subgroups of endometrial carcinoma in ovarian endometrioid carcinoma: A quantitative systematic review.
D'Alessandris N; Travaglino A; Santoro A; Arciuolo D; Scaglione G; Raffone A; Inzani F; Zannoni GF
Gynecol Oncol; 2021 Nov; 163(2):427-432. PubMed ID: 34446267
[TBL] [Abstract][Full Text] [Related]
6. TCGA molecular subgroups and FIGO grade in endometrial endometrioid carcinoma.
Travaglino A; Raffone A; Mollo A; Borrelli G; Alfano P; Zannoni GF; Insabato L; Zullo F
Arch Gynecol Obstet; 2020 May; 301(5):1117-1125. PubMed ID: 32253551
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification.
Santoro A; Angelico G; Travaglino A; Raffone A; Arciuolo D; D'Alessandris N; Inzani F; Zannoni GF
Gynecol Oncol; 2021 May; 161(2):629-635. PubMed ID: 33712277
[TBL] [Abstract][Full Text] [Related]
8. Clinico-pathological features associated with mismatch repair deficiency in endometrial undifferentiated/dedifferentiated carcinoma: A systematic review and meta-analysis.
Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Riccardi C; Mollo A; Zullo F; Insabato L
Gynecol Oncol; 2021 Feb; 160(2):579-585. PubMed ID: 33276986
[TBL] [Abstract][Full Text] [Related]
9. Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Hoang LN; Kinloch MA; Leo JM; Grondin K; Lee CH; Ewanowich C; Köbel M; Cheng A; Talhouk A; McConechy M; Huntsman DG; McAlpine JN; Soslow RA; Gilks CB
Am J Surg Pathol; 2017 Feb; 41(2):245-252. PubMed ID: 28079598
[TBL] [Abstract][Full Text] [Related]
10. Undifferentiated-dedifferentiated endometrial carcinoma; the reappearance of an old friend with insights into the new data.
Mourtzoukou D; Thomakos N; Lazaris AC; Vlachodimitropoulos D; Goutas N; Sotiropoulou M; Rodolakis A; Nonni A
APMIS; 2023 Jun; 131(6):229-236. PubMed ID: 36965090
[TBL] [Abstract][Full Text] [Related]
11. p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification.
Jamieson A; Thompson EF; Huvila J; Gilks CB; McAlpine JN
Int J Gynecol Cancer; 2021 Jun; 31(6):907-913. PubMed ID: 33589443
[TBL] [Abstract][Full Text] [Related]
12. Classification of high-grade endometrium carcinomas using molecular and immunohistochemical methods.
Bayramoglu D; Seçilmiş Kerimoğlu Ö; Bayramoğlu Z; Çintesun E; Şahin G; Karabağlı P; Çelik Ç
Ginekol Pol; 2023; 94(1):3-11. PubMed ID: 35072228
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients.
Wu Q; Zhang N; Xie X
BMC Cancer; 2022 Nov; 22(1):1157. PubMed ID: 36357827
[TBL] [Abstract][Full Text] [Related]
14. Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology.
Akhtar M; Al Hyassat S; Elaiwy O; Rashid S; Al-Nabet ADMH
Adv Anat Pathol; 2019 Nov; 26(6):421-427. PubMed ID: 31567131
[TBL] [Abstract][Full Text] [Related]
15. Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel.
Kobayashi Y; Kitazono I; Akahane T; Yanazume S; Kamio M; Togami S; Nohara S; Sakamoto I; Yokoyama S; Tabata K; Kobayashi H; Tanimoto A
Pathol Oncol Res; 2021; 27():1610013. PubMed ID: 35002543
[TBL] [Abstract][Full Text] [Related]
16. [Current prerequisites for a molecular genetic classification of endometrial cancer].
Vtorushin SV; Malykh RD
Arkh Patol; 2017; 79(3):57-62. PubMed ID: 28631718
[TBL] [Abstract][Full Text] [Related]
17. High-grade endometrial carcinomas: Morphologic spectrum and molecular classification.
Zhang C; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):176-186. PubMed ID: 34852949
[TBL] [Abstract][Full Text] [Related]
18. Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
Carlson J; McCluggage WG
Curr Opin Oncol; 2019 Sep; 31(5):411-419. PubMed ID: 31261170
[TBL] [Abstract][Full Text] [Related]
19. Histopathological characterization of ProMisE molecular groups of endometrial cancer.
Raffone A; Travaglino A; Mascolo M; Carotenuto C; Guida M; Mollo A; Insabato L; Zullo F
Gynecol Oncol; 2020 Apr; 157(1):252-259. PubMed ID: 31932106
[TBL] [Abstract][Full Text] [Related]
20. Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification.
Kim SR; Cloutier BT; Leung S; Cochrane D; Britton H; Pina A; Storness-Bliss C; Farnell D; Huang L; Shum K; Lum A; Senz J; Lee CH; Gilks CB; Hoang L; McAlpine JN
Gynecol Oncol; 2020 Jul; 158(1):3-11. PubMed ID: 32331700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]